# HRME in the Screening of Cervical Cancer Precursor Lesions in Brazil (UH3 - Brazil)

> **NCT03195218** · NA · UNKNOWN · sponsor: **Barretos Cancer Hospital** · enrollment: 1780 (estimated)

## Conditions studied

- Intraepithelial Neoplasia
- Intraepithelial Neoplasm, Cervical
- Cervical Cancer
- Neoplasm Cervix

## Interventions

- **DEVICE:** HRME examination

## Key facts

- **NCT ID:** NCT03195218
- **Lead sponsor:** Barretos Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-01
- **Primary completion:** 2019-05-31
- **Final completion:** 2019-05-31
- **Target enrollment:** 1780 (ESTIMATED)
- **Last updated:** 2017-06-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03195218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03195218, "HRME in the Screening of Cervical Cancer Precursor Lesions in Brazil (UH3 - Brazil)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03195218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*